Possible role of methylglyoxal and glyoxalase in arthritis

Biochemical Society Transactions

Volumn 42, Issue 2, 2014, Pages 538-542

  Ahmed, Usman ^a   Thornalley, Paul J ^a   Rabbani, Naila ^a  

^a UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

Glycation; Glyoxalase; Inflammation; Osteoarthritis; Receptor for advanced glycation end products (RAGE); Rheumatoid arthritis

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; AUTOANTIBODY; CELL SURFACE RECEPTOR; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; GLYOXALASE; GLYOXYLASE I; METHYLGLYOXAL; PENTOSIDINE; PROTEIN S 100; PROTEIN S100A12; RHEUMATOID FACTOR; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; LACTOYLGLUTATHIONE LYASE;

ANTIBODY DETECTION; BONE REMODELING; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE COURSE; DISEASE MARKER; EARLY DIAGNOSIS; GLYCATION; HUMAN; INFLAMMATION; JOINT DEGENERATION; JOINT INJURY; NONHUMAN; OSTEOARTHRITIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SYNOVIUM; ANIMAL; ENZYMOLOGY; METABOLISM;

ANIMALS; ARTHRITIS, RHEUMATOID; HUMANS; INFLAMMATION; LACTOYLGLUTATHIONE LYASE; OSTEOARTHRITIS; PYRUVALDEHYDE; RECEPTORS, IMMUNOLOGIC;

EID: 84896904807     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20140024     Document Type: Review

References (46)

1. Connelly, L.B., Woolf, A. and Brooks, P. (2006) Cost-effectiveness of interventions for musculoskeletal conditions. In Disease Control Priorities in Developing Countries (Jamieson, D.T., Breman, J.G., Measham, A.R., Alleyne, G., Claeson, M., Evans, D.B., Jha, P., Mills, A. and Musgrove, P., eds), pp. 963-980, World Bank, Washington DC
2. Iorio, R., Robb, W.J., Healy, W.L., Berry, D.J., Hozack, W.J., Kyle, R.F., Lewallen, D.G., Trousdale, R.T., Jiranek, W.A., Stamos, V.P. and Parsley, B.S. (2008) Orthopaedic surgeon workforce and volume assessment for total hip and knee replacement in the united states: preparing for an epidemic. J. Bone Joint Surg. Am. 90, 1598-1605 (Pubitemid 351947604)
3. Burr, D.B. and Gallant, M.A. (2012) Bone remodelling in osteoarthritis. Nat. Rev. Rheumatol. 8, 665-673
4. Ishijima, M., Watari, T., Naito, K., Kaneko, H., Futami, I., Yoshimura-Ishida, K., Tomonaga, A., Yamaguchi, H., Yamamoto, T., Nagaoka, I. et al. (2011) Relationships between biomarkers of cartilage, bone, synovial metabolism and knee pain provide insights into the origins of pain in early knee osteoarthritis. Arthritis Res. Ther. 13, R22
5. Lotz, M. and Loeser, R.F. (2012) Effects of aging on articular cartilage homeostasis. Bone 51, 241-248
6. Kapoor, M., Martel-Pelletier, J., Lajeunesse, D., Pelletier, J.P. and Fahmi, H. (2011) Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat. Rev. Rheumatol. 7, 33-42
7. Isaacs, J.D. (2010) The changing face of rheumatoid arthritis: sustained remission for all? Nat. Rev. Immunol. 10, 605-611
8. Prete, M., Racanelli, V., Digiglio, L., Vacca, A., Dammacco, F. and Perosa, F. (2011) Extra-articular manifestations of rheumatoid arthritis: an update. Autoimmun. Rev. 11, 123-131
9. Okroj, M., Heinegård, D., Holmdahl, R. and Blom, A.M. (2007) Rheumatoid arthritis and the complement system. Ann. Med. 39, 517-530 (Pubitemid 350035568)
10. Feldmann, M. and Maini, R.N. (2001) Anti-TNFα therapy of rheumatoid arthritis: what have we learned? Annu. Rev. Immunol. 19, 163-196 (Pubitemid 32368033)
11. Choy, E.H. S. and Panayi, G.S. (2001) Cytokine pathways and joint inflammation in rheumatoid arthritis. N. Engl. J. Med. 344, 907-916 (Pubitemid 32224400)
12. Kim, D.A. and Kim, T.Y. (2012) Is serum anti-cyclic citrullinated peptide level useful in the diagnosis of rheumatoid arthritis? Clin. Chim. Acta 413, 831-832
13. Besada, E., Nikolaissen, C. and Nossent, H. (2012) Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker? Scand. J. Rheumatol. 41, 85-88
14. Newkirk, M., Goldbach-Mansky, R., Lee, J., Hoxworth, J., McCoy, A., Yarboro, C., Klippel, J. and El-Gabalawy, H. (2003) Advanced glycation end-product (AGE)-damaged IgG and IgM autoantibodies to IgG-AGE in patients with early synovitis. Arthritis Res. Ther. 5, 1-9
15. Drinda, S., Franke, S., Canet, C.C., Petrow, P., Brauer, R., Huttich, C., Stein, G. and Hein, G. (2002) Identification of the advanced glycation end products Nε-carboxymethyllysine in the synovial tissue of patients with rheumatoid arthritis. Ann. Rheum. Dis. 61, 488-492
16. Schwab, W., Friess, U., Hempel, U., Schulze, E., Makita, Z., Kasper, M. and Simank, H.G. (2002) Immunohistochemical demonstration of N ε-(carboxymethyl)lysine protein adducts in normal and osteoarthritic cartilage. Histochem. Cell Biol. 117, 541-546
17. Vos, P.A.J.M., DeGroot, J., Huisman, A.M., Oostveen, J.C.M., Marijnissen, A.C.A., Bijlsma, J.W.J., van El, B., Zuurmond, A.M. and Lafeber, F.P.J.G. (2010) Skin and urine pentosidine weakly correlate with joint damage in a cohort of patients with early signs of osteoarthritis (CHECK). Osteoarthritis Cartilage 18, 1329-1336
18. Hunter, D.J., LaValley, M., Li, J., Zhang, Y., Bauer, D., Nevitt, M., Guermazi, A., DeGroot, J., Sakkee, N., Gale, D. and Felson, D.T. (2007) Urinary pentosidine does not predict cartilage loss among subjects with symptomatic knee OA: the BOKS Study. Osteoarthritis Cartilage 15, 93-97 (Pubitemid 46117913)
19. Špaček, P. and Adam, M. (2006) Pentosidine in osteoarthritis: HPLC determination in body fluids and in tissues. Rheumatol. Int. 26, 923-927 (Pubitemid 43962123)
20. Wang, F., Zhao, Y., Niu, Y., Wang, C., Wang, M., Li, Y. and Sun, C. (2012) Activated glucose-6-phosphate dehydrogenase is associated with insulin resistance by upregulating pentose and pentosidine in diet-induced obesity of rats. Horm. Metab. Res. 44, 938-942
21. Schmidt, A.M., Hori, O., Chen, J.X., Li, J.F., Carndall, J., Zhang, J., Cao, R., Yan, D.S., Brett, J. and Stern, D. (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells in mice: a potential mechanism for the accelerated vasculopathy of diabetes. J. Clin. Invest. 96, 1395-1403
22. Yonekura, H., Yamamoto, Y., Sakurai, S., Petrova, R.G., Abedin, M.J., Li, H., Yasui, K., Takeuchi, M., Makita, Z., Takasawa, S. et al. (2003) Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury. Biochem. J. 370, 1097-1109 (Pubitemid 36399105)
23. Chavakis, T., Bierhaus, A., Al Fakhri, N., Schneider, D., Witte, S., Linn, T., Nagashima, M., Morser, J., Arnold, B., Preissner, K.T. and Nawroth, P.P. (2003) The pattern recognition receptor (RAGE) is a counterreceptor for leukocyte integrins: a novel pathway for inflammatory cell recruitment. J. Exp. Med. 198, 1507-1515 (Pubitemid 37467165)
24. Neeper, M., Schmidt, A.M., Brett, J., Yan, S.D., Wang, F., Pan, Y.C.E., Elliston, K., Stern, D. and Shaw, A. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation endproducts of proteins. J. Biol. Chem. 267, 14998-15004
25. Cheng, C.M., Tsuneyama, K., Kominami, R., Shinohara, H., Sakurai, S., Yonekura, H., Watanabe, T., Takano, Y., Yamamoto, H. and Yamamoto, Y. (2005) Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs. Mod. Pathol. 18, 1385-1396 (Pubitemid 41348659)
26. Park, L., Raman, K.G., Lee, K.J., Lu, Y., Ferran, Jr, L.J., Chow, W.S., Stern, D. and Schmidt, A.M. (1998) Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat. Med. 4, 1025-1030
27. Sakaguchi, T., Yan, S.F., Yan, S.D., Belov, D., Rong, L.L., Sousa, M., Andrassy, M., Marso, S.P., Duda, S., Arnold, B. et al. (2003) Central role of RAGE-dependent neointimal expansion in arterial restenosis. J. Clin. Invest. 111, 959-972 (Pubitemid 36397472)
28. Liliensiek, B., Weigand, M.A., Bierhaus, A., Nicklas, W., Kasper, M., Hofer, S., Plachky, J., Grone, H.J., Kurschus, F.C., Schmidt, A.M. et al. (2004) Receptor for advanced glycation end products (RAGE) regulates sepsis but not the adaptive immune response. J. Clin. Invest. 113, 1641-1650 (Pubitemid 39071688)
29. Thornalley, P.J. (2007) Dietary AGEs and ALEs and risk to human health by their interaction with the receptor for advanced glycation endproducts (RAGE): an introduction. Mol. Nutr. Food Res. 51, 1107-1110
30. Huttunen, H.J., Fages, C. and Rauvala, H. (1999) Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-κ B require the cytoplasmic domain of the receptor but different downstream signaling pathways. J. Biol. Chem. 274, 19919-19924
31. Andrassy, M., Igwe, J., Autschbach, F., Volz, C., Remppis, A., Neurath, M.F., Schleicher, E., Humpert, P.M., Wendt, T., Liliensiek, B. et al. (2006) Posttranslationally modified proteins as mediators of sustained intestinal inflammation. Am. J. Pathol. 169, 1223-1237 (Pubitemid 351194359)
32. Drinda, S., Franke, S., Ruster, M., Petrow, P., Pullig, O., Stein, G. and Hein, G. (2005) Identification of the receptor for advanced glycation end products in synovial tissue of patients with rheumatoid arthritis. Rheumatol. Int. 25, 411-413 (Pubitemid 41186907)
33. Foell, D., Kane, D., Bresnihan, B., Vogl, T., Nacken, W., Sorg, C., FitzGerald, O. and Roth, J. (2003) Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis. Rheumatology 42, 1383-1389 (Pubitemid 37407031)
34. Nakashima, M., Sakai, T., Hiraiwa, H., Hamada, T., Omachi, T., Ono, Y., Inukai, N., Ishizuka, S., Matsukawa, T., Oda, T. et al. (2012) Role of S100A12 in the pathogenesis of osteoarthritis. Biochem. Biophys. Res. Commun. 422, 508-514
35. Wang, L.C., Zhang, H.Y., Shao, L., Chen, L., Liu, Z.H., He, X. and Gong, W.X. (2013) S100A12 levels in synovial fluid may reflect clinical severity in patients with primary knee osteoarthritis. Biomarkers 18, 216-220
36. Chayanupatkul, M. and Honsawek, S. (2010) Soluble receptor for advanced glycation end products (sRAGE) in plasma and synovial fluid is inversely associated with disease severity of knee osteoarthritis. Clin. Biochem. 43, 1133-1137
37. Chen, Y.S., Yan, W.X., Geczy, C.L., Brown, M.A. and Thomas, R. (2009) Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis. Arthritis Res. Ther. 11, R39
38. Bierhaus, A., Konrade, I., Haag, G.M., Humpert, P.M., Morcos, M., Hammes, H.P., Tew, K. and Nawroth, P.P. (2005) The receptor RAGE regulates glyoxalase-1 transcription, expression and activity. Diabetologia 48, A90
39. Zeng, S., Zhang, Q.Y., Huang, J.Z., Vedantham, S., Rosario, R., Ananthakrishnan, R., Yan, S.F., Ramasamy, R., DeMatteo, R.P., Emond, J.C. et al. (2012) Opposing roles of RAGE and MyD88 signaling in extensive liver resection. FASEB J. 26, 882-893
40. Reiniger, N., Lau, K., McCalla, D., Eby, B., Cheng, B., Lu, Y., Qu, W., Quadri, N., Ananthakrishnan, R., Furmansky, M. et al. (2010) Deletion of the receptor for advanced glycation end products reduces glomerulosclerosis and preserves renal function in the diabetic OVE26 mouse. Diabetes 59, 2043-2054
41. Xue, M., Rabbani, N., Momiji, H., Imbasi, P., Anwar, M.M., Kitteringham, N.R., Park, B.K., Souma, T., Moriguchi, T., Yamamoto, M. and Thornalley, P.J. (2012) Transcriptional control of glyoxalase 1 by Nrf2 provides a stress responsive defence against dicarbonyl glycation. Biochem. J. 443, 213-222
42. Liu, G.H., Qu, J. and Shen, X. (2008) NF-κB/p65 antagonizes Nrf2-ARE pathway by depriving CBP from Nrf2 and facilitating recruitment of HDAC3 to MafK. Biochim. Biophys. Acta 1783, 713-727
43. Hein, G.E., Kohler, M., Oelzner, P., Stein, G. and Franke, S. (2005) The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol. Int. 26, 137-141 (Pubitemid 41779823)
44. Takahashi, M., Suzuki, M., Kushida, K., Miyamoto, S. and Inoue, T. (1997) Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis. Br. J. Rheumatol. 36, 637-642
45. Takahashi, M., Kushida, K., Ohishi, T., Kawana, K., Hoshino, H., Uchiyama, A. and Inoue, T. (1994) Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum. 37, 724-728 (Pubitemid 24145077)
46. Chen, J.R., Takahashi, M., Suzuki, M., Kushida, K., Miyamoto, S. and Inoue, T. (1999) Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology 38, 1275-1278